|Year : 2018 | Volume
| Issue : 2 | Page : 43-53
Network pharmacology-based study of the active constituents of Chinese medicinal formulae for antitumor mechanism
Bao-Yue Zhang1, Yi-Fu Zheng2, Xiao-Cong Pang1, Zhe Wang1, Hong Ding2, Ai-Lin Liu3
1 Institute of Materia Medica, Chinese Academy of Medical Sciences And Peking Union Medical College, Beijing 100050, China
2 School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China
3 Institute of Materia Medica, Chinese Academy of Medical Sciences And Peking Union Medical College; Beijing Key Laboratory of Drug Target and Screening Research; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China
|Date of Web Publication||2-Jul-2018|
Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050
Source of Support: None, Conflict of Interest: None
Objective: To investigate the network pharmacology of anti-tumor Chinese medicinal formulae and explain the synergistic mechanism of various active ingredients of Chinese medicinal formulae. Methods: We collected the anti-tumor Chinese medicinal formulae and chose several single herbs with the top frequency for further study. The chemical constituents of these herbs were downloaded from databases CNPC and Traditional Chinese Medicine Systems Pharmacology and were analyzed to set up the anti-tumor material basis. The genes regulated by these constituents were retrieved in Traditional Chinese Medicine integrated database and Comparative Toxicogenomics database. Results: We collected 65 anti-tumor Chinese medicinal formulae, and 4 single herbs were selected, including Licorice, Radix astragali, Panax ginseng, and Radix scutellariae, which consist of 172, 70, 293, and 92 known constituents, respectively. The constituent–gene network, protein–protein interaction network, gene–pathway enrichment network, and gene–disease network were constructed. Moreover, molecular docking was employed to clarify the interactions between active constituents and key drug targets (PTG2, epidermal growth factor receptor, peroxisome proliferator-activated receptor gamma, estrogen receptor 1, mammalian target of rapamycin, AKT1, mitogen-activated protein kinase 1 [MAPK1], peroxisome proliferator-activated receptor alpha, and MAPK8). Most of the constituents could act on multiple targets, whose structures mainly belong to alkaloids, flavonoids, and their glycosides, organic acids, or dianthrone, and their representative chemical constituents include narcissus glycosides, rutin, dauricine, scutellarin, baicalin, isoschaftoside, and leucovorin. Conclusion: The network mechanism of the effective constituents from traditional Chinese medicines (TCMs) for anti-tumor therapy was partially uncovered by using statistical methods, network pharmacology methods, and molecular docking methods. This study will provide important information for new drug design with multiple targets for anti-tumor therapy.
Keywords: Data mining, molecular docking, network pharmacology, traditional Chinese medicine, tumor
|How to cite this article:|
Zhang BY, Zheng YF, Pang XC, Wang Z, Ding H, Liu AL. Network pharmacology-based study of the active constituents of Chinese medicinal formulae for antitumor mechanism. World J Tradit Chin Med 2018;4:43-53
|How to cite this URL:|
Zhang BY, Zheng YF, Pang XC, Wang Z, Ding H, Liu AL. Network pharmacology-based study of the active constituents of Chinese medicinal formulae for antitumor mechanism. World J Tradit Chin Med [serial online] 2018 [cited 2023 Dec 8];4:43-53. Available from: https://www.wjtcm.net/text.asp?2018/4/2/43/235826
| Introduction|| |
Cancer is generally acknowledged as a life-threatening malignant disease with increasing incidence and mortality rate. According to China's recent statistical data, the death brought by cancer has outnumbered that by cardiovascular disease, and become the most possible factor of death of rural and urban residents., At present, the medical treatment of malignant tumor is mainly about traditional surgical operation, radiotherapy, and chemotherapy. Although radiotherapy can kill tumor cells and inhibit their proliferation in short term and chemotherapy has good effect on some kinds of tumor, the specificity is both quite low; while killing the tumor cells, the therapies also inhibit the activity of the normal cells in human body. Thus, most of the therapies have serious side effects.
Traditional Chinese medical science has recognized the existence of cancer from “Shen nong's herbal classic.” From then on, doctors of traditional Chinese medicine (TCM) in every dynasty devoted themselves to explore ways to cure cancer and left us a large number of formulae, in which about 200 kinds of herbs have been proved to have antitumor effects. Compared to the traditional radiotherapy and chemotherapy in Western medicine, TCM has the advantages of wide source, low price, and little side effects as well as the same antitumor effect. In addition, it can also play an important role in improving immunity, improving patients' quality of life, preventing relapse and metastasis of tumor cells, and extending survival time. In combination with TCM and Western medicine, the use of Chinese herbs can enhance the sensitivity of radiotherapy and chemotherapy and reduce the adverse effects of radiotherapy and chemotherapy. Compared with Western medicine, TCM has unique advantages in individualized treatment, which helps to select suitable drugs for patients and improve treatment pertinence. As a result, TCM has been taken as a common adjuvant therapy in China's hospitals to assist curing cancer.
At present, Chinese medical formula has played an important role in different stages of the treatment of tumor, and its curative effect has been fully affirmed, which made it become one of the hot spots in studies of TCM. TCM has the characteristics of multicomponents, multitargets, and diverse modes of regulation. It is difficult to reflect the systematic  TCM by Western single-target and single-component research method, which cannot explain scientifically the material basis and prescription rules of Chinese herbal compound. Hopkins  proposed the network pharmacology research method and believed that the drug acts on multiple targets and produces synergistic and attenuating effects through interactions between multiple targets. Network pharmacology studies problems from the perspective of mutual connection, which exactly coincides with the core ideas of TCM. Therefore, the application of network pharmacology to TCM has unique advantages and great potential for development. In the wake of modernization in Chinese medicine these years, several Chinese medicine databases (TCMID, Comparative Toxicogenomics Database [CTD], Traditional Chinese Medicine Systems Pharmacology [TCMSP], HIT, TCMDB at Taiwan, etc.) have been established. Based on data mining on current databases and analysis in bioinformatics together with computational simulation method, we can find a convenient and effective means for uncovering the network mechanism of TCM.
We first collected five main categories of antitumor Chinese medical formulae, which are divided by its function that include strengthening the body resistance, clearing away heat and toxic material, activating blood circulation to dissipate blood stasis, resolving hard lump, and reducing phlegm and dampness. We chose several single herbs from those formulae with top frequency. Then they were analyzed to set up the antitumor material basis. On the basis of collecting herbs' chemical constituents and analyzing its gene regulation effect, we carried out Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene ontology (GO) enrichment analysis and constructed constituent–gene network, protein–protein interaction network, gene–pathway network, and gene–disease network to explain the network mechanism of the herbs' antitumor effect. At last, the network of chemical constituent–genes was constructed, and based on the corresponding targets of crucial genes, the molecular docking models were established to further confirm the mechanism of chemical constituents against antitumor targets, and therefore provide important information for multitarget drug design in cancer therapy afterward.
| Materials and Methods|| |
Chinese medicinal formula and monomers
TCM compound is the basic form of TCM for the prevention and treatment of diseases, that is, a mixture of certain quantitative Chinese herbal plants. TCM compound contains a large number of chemical substances, which are the material basis for the interaction with multiple disease-related targets. The antitumor formulae are collected through the two ways described as follows: (1) Inquire information in the modern application database of prescriptions (http://cowork.cintcm. com/engine/login_do.jsp?u=guestandp=uest321andcnid=12895) with “cancer” or “tumor” as the keywords; (2) Inquire information in CNKI and PubMed databases. On this basis, the frequency of occurrence of each herb was ranked. Four herbs with a frequency of >10 were chosen for further study. All constituents from these four herbs were collected from CNPC (http://pharmdata.ncmi.cn/cnpc/) and TCMSP database (http://ibts.hkbu.edu.hk/LSP/tcmsp.php).
The collection of regulated genes and targets
For the known ingredients of TCMs, we used the TCMID (http://www.megabionet.org/tcmid/) and CTD (http://ctdbase.org/) to analyze their targets. TCMID consists of six parts and they are prescriptions, herbs, ingredients, targets, drugs, and diseases. TCMID identifies the potential interaction between chemical constituents and targets through data mining of STITCH, herb ingredients' targets, and literature. CTD provides the information about constituent–gene/protein interactions, constituent–disease and gene–disease interactions, of which the constituent–gene/protein interaction data are from the reported literature.
We used FunRich 2.1.2 (http://www.funrich.org) to analyze the distribution of genes regulated by active ingredients in Chinese medicines and obtained the co-regulated genes. On the one hand, KEGG and GO enrichment analysis was performed on regulated genes from each herb to analyze the antitumor effect. On the other hand, we constructed the constituent–gene network on the basis of co-regulated genes. The STRING database was used to predict the relationship of genes and construct a protein–protein interaction network. The metabolic pathways regulated by constituents in Chinese medicine were GO, KEGG, and OMIM enrichment analyzed by using DAVID database to construct the gene–pathway network and gene–disease network.
Cytohubba is the plug-in component of Cytoscape_3.2.1 and it can help find out the key nodes from the protein–protein interaction network. Pick out the targets of marketed drugs or drugs at Phase II clinical trials to construct molecular docking models. The crystal structures of these target proteins were downloaded from the PDB (Protein Data Bank) database. To ensure the reliability of molecular docking, we chose protein crystal structures containing co-crystallized ligand with a resolution of <2.5 Å to establish molecular docking models. The molecular docking was processed with the Libdock software package of Discovery Studio 2016 (San Diego, CA, USA). Before docking, the co-crystallized water was removed, and the polar hydrogen and incomplete residues were added. The active pocket of the docking is defined by the primitive ligand molecule. After setting the docking parameters, the ligand molecule was extracted from the crystal structure and redocked to the predefined active pocket. The root-mean-square deviation (RMSD) was used to compare differences between the atomic distances of the docked poses and the real co-crystallized pose to measure docking reliability.
| Results|| |
Antitumor Chinese medicinal formulae and chemical constituent collection
A total of 65 traditional Chinese medicinal formulae for the treatment of cancer were collected through the modern application database of prescriptions and literature search, which include strengthening the body resistance type compounds, clearing away heat and toxic material type compounds, activating blood circulation to dissipate blood stasis type compounds, resolving hard lump type compounds, and reducing phlegm and dampness type compounds. Then we analyzed the frequency of occurrence of single herbs in these formulae and the results were shown in [Figure 1]. There are four herbs with a frequency of >10, which are licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae. The main chemical constituents contained in the four herbs were collected from China Natural Product Database and TCMSP Database; the active constituents among them were collected from TCMID and CTD Databases. [Table 1] shows the active ingredients statistics of the four herbs.
|Figure 1: Frequency of herbs in the Chinese medicinal formula for antitumor therapy|
Click here to view
|Table 1: The constituents statistics of the four herbs, licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae|
Click here to view
Antitumor material basis
We studied the antitumor material basis of four herbs, namely licorice, Radix astragali, Panax ginseng, and Radix scutellariae, through the method of literature research.
The triterpenes and flavonoid components from licorice and the extracts from licorice have significant inhibitory effects on colorectal, breast, prostate, liver, stomach, bladder, and lung cancers. Khan et al. pointed out that the constituent glycyrrhizin can significantly reduce the level of tumor necrosis factor-alpha and weaken the mucus layer depletion and the transfer from sialic mucin to sulphomucin; Glycyrrhizin has strong chemopreventive potential for 1,2-dimethylhydrazine-induced colon cancer. There are many literatures studying the antitumor activity of licorice, among which most focus is on the anti-breast cancer activity. Hsu et al. pointed out that the constituent glabridin can inhibit the invasion, metastasis, and angiogenesis of malondialdehyde (MDA)-MB-231 human breast cancer cells by inhibiting the focal adhesion kinase/Rho signaling pathway. Lee et al. found that compound isoangustone A is a potent inhibitor of CDK2 for the treatment of prostate cancer. Lin et al. reported that the constituent glycyrrhetinic acid can effectively inhibit the tumor formation of gastric cancer cells in nude mice by inducing gastric cancer cell apoptosis and arresting the cell cycle in G2 phase. Tsai et al. reported that the constituent licochalcone A can inhibit the migration and invasion of human hepatocellular carcinoma cells SK-Hep-1 and HA22T/VGH. This compound was found to inhibit the activity and expression of uPA and reduce the uPA transcription level in the above cells. Yuan et al. found that the constituent licochalcone B significantly inhibited the proliferation of human bladder cancer T24 and EJ cell lines in a concentration- and time-dependent manner. Tsai et al. reported that the constituent glabridin inhibited the invasion and metastasis of human non-small cell lung cancer A549 cells and reduced A549-mediated angiogenesis by inhibiting the FAK/Rho signaling pathway.
Radix Astragali contains a variety of active ingredients, including polysaccharides, flavonoids, saponins, amino acids, and a variety of trace elements. Its antitumor mechanisms mainly include inhibiting tumor cell proliferation, promoting tumor cell apoptosis, inhibiting tumor cell migration, scavenging free radicals, and enhancing immune function. Li et al. studied the influence of Radix Astragali polysaccharide (APS) on human erythroleukemia K562 cell proliferation and apoptosis, proving that APS may inhibit the proliferation of K562 cells by the downregulation of Cyclin B and Cyclin E and the upregulation of the level of p21. Wang et al. observed the changes of cell cycle and apoptosis rate of BGC-823 cells treated with total flavonoids of Radix Astragali by flow cytometry and found that total flavonoids of Radix Astragali could delay the cell cycle of BGC-823 cells at G0/G1 phase in a dose-dependent manner. The experimental results of Cheng et al. showed that astragaloside reduced the expression of matrix metalloproteinase (MMP-2) and MMP-9 through the pathway of protein kinase C-α-extracellular and regulated protein kinase (ERK1)/2-nuclear factor kappa B, thereby inhibiting the cell metastasis of lung cancer A549. Yin et al. proved that Radix Astragali extract can significantly reduce the expression of cyclooxygenase-2 and vascular endothelial growth factor in stage I tumors, suggesting that Radix Astragali extract can inhibit tumor cell migration. Another study , found that astragaloside, calycosin, and formononetin have anti-oxidative activity and can scavenge free radicals. In addition, Radix Astragali injection and its polysaccharides can not only increase superoxide dismutase activity, reduce MDA content, and eliminate reactive oxygen species (ROS) and reactive nitrogen species produced by intracellular oxidative stress, but also reduce free radical generation. Zhang et al. detected the ratio of regulatory T cells (Tregs) and cytotoxic T lymphocytes (CTLs) in mice with lung cancer which were treated by oral administration of astragaloside using flow cytometry and found that the proportion of Treg decreased while the proportion of cytotoxic T lymphocytes (CTLs) increased in the spleen, suggesting that astragaloside may inhibit tumor growth by enhancing immune function.
The main antitumor ingredients in Panax Ginseng mainly include ginsenosides and their metabolites, Panax Ginseng polysaccharides, and Panax Ginseng alkynyl alcohol. According to the currently reported literature, Panax Ginseng has a significant inhibitory effect on liver cancer, stomach cancer, lung cancer, kidney cancer, squamous cell carcinoma, nasopharyngeal cancer, esophageal cancer, colon cancer, gallbladder cancer, melanoma, glioma, breast cancer, papilloma, ovarian cancer, cervical cancer, endometrial cancer, bladder cancer, prostate cancer, ascites cancer, lymphoma, myeloma, osteosarcoma, leukemia, and other tumor proliferation. Studies have shown that 20 (S)-ginsenoside Rg3,, ginsenoside Rd, PNT, and PNN  can inhibit tumor cell mitosis and DNA synthesis in the interphase, as in colon cancer cells, the expression of proliferation-related protein and proliferating cell nuclear antigen is inhibited, leading to the reduction of DNA replication and repair, thereby inhibiting cell proliferation. Ginsenosides such as Rg3, Rg5, CK, and 25-OH-PPD  work in the regulation of cell cycle-related proteins such as breast cancer, gastric cancer, lung cancer, and prostate cancer; the tumor cell cycle is arrested in G0/G1 phase in the end. Ginsenosides Rg5, Rh2, Rk1, CK, and PPD  can induce endogenous apoptosis of tumor cells. Ginsenosides Rh2, Rk1, CK, and PPD  can induce exogenous apoptosis of tumor cells. Currently, Panax Ginseng-induced differentiation of tumor cells is mainly directed against leukemia. Studies have shown that ginsenosides induce leukemia cells to differentiate into erythroid cells by the internalization of the erythropoietin receptor. Another study has shown that active ingredients in Panax Ginseng can significantly inhibit the invasion and metastasis of a variety of tumors. Ginsenosides such as Rb2, Rg1, Rg3,, Rh1, Rh2, Rd, and CK  can inhibit the invasion and metastasis of cancer cells by inhibiting the expression of MMP-1, 2, 3, 7, 9, 13, and 14 and other MMPs in cancer cells to avoid their destruction of extracellular matrix (ECM) barrier.
The ant-tumor effect of Radix Scutellariae is mainly manifested by flavonoids, including baicalein, baicalin, wogonin, and Oroxylin A, which can affect cell cycle, induce tumor cell apoptosis, and inhibit telomerase activity. It was reported that wogonin can inhibit the proliferation of SK-HEP-1 cells (IC50 =80 μmol/L) and induce the apoptosis of SK-HEP-1 cells and enhance the activity of Caspase-3/cpp32. Wang et al. found that baicalein can induce mitochondria to release cytochrome C in HL-60 cells, resulting in elevated levels of H2O2 in cells, thereby inducing apoptosis and DNA fracture. The catalase can effectively block baicalein-induced apoptosis and DNA fragmentation, indicating that baicalein may induce cell apoptosis through ROS-mediated mitochondrial dysfunction. Baicalein, baicalin, and wogonin can inhibit liver tumor cell HepG2, Hep3B, and SK-HEP1 proliferation. All the three constituents can block the cell cycle of HepG2 cells in G2/M phase and Hep3B cells in G1 subphase. Baicalein and wogonin block the cell cycle of SK-HEP1 cells in G1 and G1 phases, respectively.,, Huang et al. found that the inhibitory effect of wogonin on the proliferation of HL-60 cells (IC50 = 50 μmol/L) was related to the decrease of telomerase activity. Zhang et al. found that the tumor volume was significantly reduced and the tumor growth inhibition rate was 66% in HNSCC model mice fed with flavonoids from Radix Scutellariae. Administered with Oroxylin A (40 mg/kg), the tumor volume of melanoma B16-F10 mice was reduced by 73%.
Enrichment analysis of the regulated gene
According to TCMID and CTD databases, the number of genes regulated by active ingredients from licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae is 521, 576, 208, and 678, respectively. There are 80 genes co-regulated by the four herbs [Figure 2]. The genes from the four herbs undergo KEGG pathway enrichment analysis, and five pathways are listed in [Table 2] according to the number of enriched genes and P value. All the pathways in [Table 2] have been reported in the literature, which shows our experimental results are reliable. The four herbs share some similarities in pathways and they all act on the toll-like receptor signaling pathway. Moreover, licorice acts more similar with Panax Ginseng and Radix Astragali acts more similar with Radix Scutellariae. Using Funrich 2.1.2, their GO pathways and molecular functions were enriched. [Figure 3] shows that licorice and Panax Ginseng mainly act on serine proteases activity, while Radix Astragali and Radix Scutellariae mainly have effects on tyrosine kinase activity and transcription factors activity, respectively. From the GO_BP enrichment analysis [Figure 4], we can see that all of the four herbs have a great influence on both energy and metabolic pathways.
|Figure 2: Venn diagram of genes related to the four herbs for antitumor mechanism|
Click here to view
|Table 2: Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of the regulated gene of Licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae|
Click here to view
|Figure 3: (a) Gene ontology molecular function enrichment for Licorice, (b) Radix Astragali, (c) Panax Ginseng, and (d) Radix Scutellariae|
Click here to view
|Figure 4: (a) Gene ontology biological process for Licorice, (b) Radix Astragali, (c) Panax Ginseng, and (d) Radix Scutellariae|
Click here to view
Analysis of network mechanism
Venn diagram [Figure 2] shows the four single herbs' co-regulated 80 genes, indicating that they share a common antitumor mechanism. Therefore, we enrichment analyzed the 80 genes to illustrate the regulation effects of chemical constituents on related diseases and the relationship between pathways and related diseases. [Figure 5] shows that most of the chemical constituents can regulate multiple genes, which are potential multitarget chemicals. [Figure 6] shows the common pathways regulated by these genes, including toll-like receptor signaling pathway, p53 signaling pathway, adipocytokine signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, and T-cell-related immune signaling pathway. From [Figure 7], we can find that these herbs are involved in a variety of cancers, such as prostate cancer, breast cancer, and melanoma. What's more, these four herbs also have effects on the signaling pathways related to Alzheimer's disease and type II diabetes.
|Figure 5: The constituent − gene network for potential regulators in Licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae (threshold: count = 2, P < 0.05). The blue circle means gene and the green circle means constituent|
Click here to view
|Figure 6: The enrichment analysis of gene–pathway network by Kyoto Encyclopedia of Genes and Genomes (threshold: count = 2, P < 0.05). The blue square means gene and the purple square means Kyoto Encyclopedia of Genes and Genomes Pathway|
Click here to view
|Figure 7: The interaction analysis of gene–disease network (threshold: count = 2, P < 0.05). The blue circle means gene and the brown circle means disease|
Click here to view
Through gene–gene interaction [Figure 8] and hub gene analysis, we identified nine targets with either marketed drugs or drugs at phase II clinical trials. They are PTG2, epidermal growth factor receptor (EGFR), peroxisome proliferator-activated receptor gamma, estrogen receptor 1 (ESR1), mammalian target of rapamycin (MTOR), AKT1, MAPK1, peroxisome proliferator-activated receptor alpha, and MAPK8. We reveal the interaction of chemical constituents and targets by molecular docking model. Before the molecular docking between the chemical constituent and the target is conducted, the ligand in the target crystal structure is verified by re-docking. The spatial coordinates of the docked ligand and the ligand in the target are compared to get the RMSD value. When RMSD is <2.5, it indicates that the docking results are reliable [Table 3]. Furthermore, based on the chemical constituent–gene regulation network shown in [Figure 5], we investigate the interaction of these valid chemical compositions with nine core targets. [Table 4] shows the information of the top five chemical components after each target is docked. Most of the compounds can act on multiple targets, such as narcissin, rutin, dauricine, scutellarin, baicalin, isoschaftoside, leucovorin, and pseudo-hypericin, whose structures mainly belong to alkaloids, flavonoids and their glycosides, organic acids, or dianthrone. These scaffolds provide the structural basis for multitarget compound design. Taking lycorine with the most frequent occurrence as an example, we studied its interaction with multiple targets. [Figure 9] exemplifies that narcissin binds to multiple targets via hydrogen bonds, Pi bonds, and the attraction between ions.
|Figure 8: The analysis of gene–gene interaction network by STRING (edge value cutoff of 0.70). The red triangles mean hub genes and were used for molecular docking|
Click here to view
|Table 3: The target used for docking and their protein data bank ID, resolution, and root-mean-square deviation for validation|
Click here to view
|Table 4: The top five constituents with highest docking scores of each target|
Click here to view
|Figure 9: (a) Narcissin has a wide interaction with multiple targets, including estrogen receptor 1, (b) mitogen-activated protein kinase/JNK1, (c) epidermal growth factor receptor, (d) AKT1, (e) mammalian target of rapamycin and (f) MAKP1/ERK2. The binding modes and docking scores were listed|
Click here to view
| Discussion and Conclusion|| |
As a major component of traditional medicine, TCM has played an important role in cancer prevention over thousands of years. However, since the composition of TCM is complicated and tumor is also a multifactor complex disease, the pharmacological mechanism of Chinese medicine for cancer treatment is not yet clear. The chemical compositions from licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae are complex, mainly including triterpenes, flavonoids, polysaccharides, saponins, amino acids, and acetylenic alcohols; they all showed good antitumor activity, which laid a good material foundation for the study of pharmacological network mechanism of these four herbs.
In this article, we explore the antitumor mechanism of four representative single herbs, namely, licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae through the data mining and computational simulation and other methods. The gene enrichment results showed that licorice and Panax Ginseng activate the immune response and enhance immune function by affecting toll-like and Nucleotide oligomerization domain (NOD)-like receptor signaling pathways. Licorice is closely related to the synthesis of steroid hormones, which can explain why there are so many reports about anti-breast cancer activity of Licorice. What's more, we found that licorice can act on a variety of CYP450, which makes licorice an antidote, helping ease the drug potent. However, we should also pay attention to the combination of licorice and Western medicine to avoid the side effects caused by the induction or inhibition of metabolism. In addition to the pathways directly related to cancer, the chemical compositions from Panax Ginseng can also affect the adipokine signaling pathway. Recent studies show that adipose tissue is a metabolically active secretion organ and can secrete a variety of tumor-associated adipokines. In the process of multiple types of tumor progression, adipocyte metabolism and secretion in the tumor microenvironment have received extensive attention. Tumor occurrence and metastasis are closely related to the microenvironment. Therefore, the effect of Panax Ginseng in adipokine signaling pathway provides a new direction for its antitumor mechanism. By KEGG and GO enrichment analysis, we found that Radix Astragali can inhibit tumor cell proliferation, promote tumor cell apoptosis, inhibit tumor cell migration, and enhance the immune function through affecting apoptosis pathway, p53 signaling pathway, cell adhesion, and toll-like signal transduction pathway, which are consistent with the literature. What's more, we also found that Radix Astragali can significantly affect the adipokine signaling pathway and tumor microenvironment.
Through the analysis of 80 core genes co-regulated by four single herbs, we found that the regulation of chemical compositions toward gene is a many-to-many relationship. Multicomponent Chinese traditional medicine and multigene regulation mechanism determine its broad-spectrum antitumor effect. [Figure 7] shows that these four herbs have effects on a variety of tumors including prostate cancer, small cell lung cancer, thyroid cancer, kidney cancer, colon cancer, melanoma, endometrial cancer, chronic myeloid leukemia, pancreatic cancer, and bladder cancer. In addition, these four herbs also have regulatory effects on Alzheimer's disease and type II diabetes, which may be related to their regulation of energy metabolism; energy metabolism is closely related to cancer, Alzheimer's disease, and diabetes. We can summarize several antitumor mechanisms of TCM from [Figure 6]: (1) Activate immune response and improve immunity by regulating B-cells, T-cells, and toll-like, NOD-like receptor signaling pathways. (2) Improve tumor microenvironment by regulating adipokines, inflammatory factors, and cell–cell adhesions. (3) Regulate tumor cell proliferation, migration, differentiation, and apoptosis by regulating tumor suppressor p53 and kinase-related metabolic pathways.
What's more, through the analysis of gene interaction networks, several key antitumor targets of licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae were identified, which are also the current representative targets for the treatment of cancer. From the molecular docking results, we can see that most of the chemical components from the four single herbs have some effects on these key targets and there are many constituents acting on multiple targets. These chemical constituents are important material bases for the antitumor effects of TCM and for the study of their mechanism of action, also providing important information for antitumor drug design with multiple targets.
This work is different from many of the previous network pharmacology-based TCM studies., Instead of conducting generic screening of compounds of TCM, we studied the antitumor effects of all chemical components and avoided the omission of the pharmacologically active compound backbone. In addition, we constructed a gene–disease network and found that these TCM is associated with a variety of cancers and also plays a role in signaling pathways associated with other diseases such as Alzheimer's disease. Finally, we not only set up networks to make predictions, but also discovered chemical constituents that act on multiple targets through molecular docking. These chemical constituents are important material bases for the antitumor effects of TCM and for the study of their mechanism of action, also providing important information for antitumor drug design with multiple targets.
In summary, we proposed an analysis method for identification of the molecular mechanisms of herbal formula based on the integration of multicomponent effects. Dependent on the collected Chinese medicinal formulae for cancer treatment, several single herbs with the top frequency were selected for further study. To explain the synergistic mechanism of various active ingredients of Chinese medicinal formula, the constituent–gene network, protein–protein interaction network, gene–pathway enrichment network, and gene–disease network were constructed on the basis of the analysis of constituents and relatively regulated genes of licorice, Radix Astragali, Panax Ginseng, and Radix Scutellariae using data mining method. The research method of this article will provide reference for the study of antitumor mechanism of other single herbs. The multitarget active chemical constituents found in the study will provide important information for the design of new antitumor drugs, and meanwhile this study will lay theoretical basis for clinical application of antitumor drugs.
Financial support and sponsorship
This work was supported by the National Natural Science Foundation of China (81673480), Beijing Natural Science Foundation (7152103), National Population and Health Scientific Data Sharing Service Platform (2016NCMIZX05, NCMI-AGD05-201709), and CAMS Initiative for Innovative Medicine (CAMS-I2M) (2016-I2M-3-007).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al
. Cancer statistics in China, 2015. CA Cancer J Clin, 2016;66:115-132.
Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X. Report of cancer incidence and mortality in China, 2010. China Cancer 2014;2:61.
Ling CQ, Yue XQ, Ling C. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J Integr Med 2014;12:331-5.
Liu X, Zhou X, Wang J, Yang H. Research progress in anti-tumor mechanism of traditional Chinese medicine. China Pharm 2016;19:1158-62.
Liu LL, Chen J, Shi YP. Advances in studies on antitumor of Chinese materia medica with heat-clearing and toxin-resolving functions. Chin Tradit Herbal Drugs 2012;43:1203-12.
Guo YP, Chen ZJ, Jin-Yun MA. Research status on quality of life in the patients with cancer. China Cancer 2008:7:600-2.
Jie L, Hong-Sheng LIN, Wei H. Idea and strategy of traditional Chinese medicine treatment for cancer. China Cancer 2010;19:735-8.
Westerhoff HV. Network-based pharmacology through systems biology. Drug Discov Today Technol 2015;15:15-6.
Hopkins AL. Network pharmacology. Nat Biotechnol 2007;25:1110-1.
Hopkins AL. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol 2008;4:682-90.
Xie T, Song S, Li S, Ouyang L, Xia L, Huang J, et al.
Review of natural product databases. Cell Prolif 2015;48:398-404.
Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T, et al.
TCMID: Traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res 2013;41:D1089-95.
Mattingly CJ, Rosenstein MC, Colby GT, Forrest JN Jr., Boyer JL. The comparative toxicogenomics database (CTD): A resource for comparative toxicological studies. J Exp Zool A Comp Exp Biol 2006;305:689-92.
Pang X, Wang L, Kang, Zhao Y, Wu S, Liu AL, et al.
Effects of P-glycoprotein on the transport of DL0410, a potential multifunctional anti-Alzheimer agent. Molecules 2017;22. pii: E1246.
Yang R, Wang LQ, Liu Y. Anti-tumor activities of widely-used Chinese herb licorice. Chin Herbal Med 2014;6:274-81.
Khan R, Khan AQ, Lateef A, Rehman MU, Tahir M, Ali F, et al.
Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. PLoS One 2013;8:e56020.
Hsu YL, Wu LY, Hou MF, Tsai EM, Lee JN, Liang HL, et al.
Glabridin, an isoflavon from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway. Mol Nutr Food Res 2011;55:318-27.
Lee E, Son JE, Byun S, Lee SJ, Kim YA, Liu K, et al.
CDK2 and mTOR are direct molecular targets of isoangustone A in the suppression of human prostate cancer cell growth. Toxicol Appl Pharmacol 2013;272:12-20.
Lin D, Zhong W, Li J, Zhang B, Song G, Hu T, et al.
Involvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growth. Nutr Cancer 2014;66:463-73.
Tsai JP, Hsiao PC, Yang SF, Hsieh SC, Bau DT, Ling CL, et al.
Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression. PLoS One 2014;9:e86537.
Yuan X, Li T, Xiao E, Zhao H, Li Y, Fu S, et al.
Licochalcone B inhibits growth of bladder cancer cells by arresting cell cycle progression and inducing apoptosis. Food Chem Toxicol 2014;65:242-51.
Tsai YM, Yang CJ, Hsu YL, Wu LY, Tsai YC, Hung JY, et al.
Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway. Integr Cancer Ther 2011;10:341-9.
Deng X, Li QS, Chen Z, Chen JY, Wang Y, Lin SQ, et al
. Advances in antitumor mechanisms of radix astragali. Tradit Chin Drug Res Clin Pharmacol 2016;27:307-312.
Chao L, Xinhua A, Xinlai Q, Lin F, Hong W. Inhibitory effect of astragalus polysaccharide on the proliferation of human erythroleukemia K562 cells and its mechanisms. Chin J Appl Clin Pediatr 2014;29:936-9.
Wang T, Xuan X, Li M, Gao P, Zheng Y, Zang W, et al.
Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells. Diagn Pathol 2013;8:179.
Cheng X, Gu J, Zhang M, Yuan J, Zhao B, Jiang J, et al.
Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway. Int Immunopharmacol 2014;23:304-13.
Yin G, Tang D, Dai J, Liu M, Wu M, Sun YU, et al.
Combination efficacy of Astragalus membranaceus
and Curcuma wenyujin
at different stages of tumor progression in an Imageable Orthotopic Nude Mouse Model of metastatic human ovarian cancer expressing red fluorescent protein. Anticancer Res 2015;35:3193-207.
Chen CY, Zu YG, Fu YJ, Luo M, Zhao CJ, Wang W, et al
. Preparation and antioxidant activity of Radix Astragali residues extracts rich in calycosin and formononetin. Biochem Eng J 2011;56:84-93.
Li J, Han L, Ma YF, Huang YF. Inhibiting effects of three components of Astragalus membranaceus on oxidative stress in Chang liver cells. Zhongguo Zhong Yao Za Zhi 2015;40:318-23.
Pu X, Fan W, Yu S, Li Y, Ma X, Liu L, et al.
Polysaccharides from Angelica
exert hepatoprotective effects against carbon-tetrachloride-induced intoxication in mice. Can J Physiol Pharmacol 2015;93:39-43.
Zhang A, Zheng Y, Que Z, Zhang L, Lin S, Le V, et al.
Astragaloside IV inhibits progression of lung cancer by mediating immune function of tregs and CTLs by interfering with IDO. J Cancer Res Clin Oncol 2014;140:1883-90.
Luo LM, Shi YN, Jiang YN, Zhan JH, Qin L, Chen NH. Advance in components with antitumor effect of Panax
ginseng and their mechanisms. Chin Tradit Herbal Drugs 2017;48:582-96.
He BC, Gao JL, Luo X, Luo J, Shen J, Wang L, et al.
Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. Int J Oncol 2011;38:437-45.
Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, et al.
Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 2009;73:811-6.
Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, et al.
Proteome changes related to the anti-cancer activity of HT29 cells by the treatment of ginsenoside Rd. Pharmazie 2009;64:242-7.
Kim JY, Lee KW, Kim SH, Wee JJ, Kim YS, Lee HJ, et al.
Inhibitory effect of tumor cell proliferation and induction of G2/M cell cycle arrest by panaxytriol. Planta Med 2002;68:119-22.
Wang Y, Zhu HT, Huang WS, Wu YY, Zhu L, Song L, et al
. Role of panaxynol on inhibiting metastasis of human pancreatic carcinoma cell line SW1990 in vitro
. Chin J Cancer Prev Treat 2015;22:1662-66.
Park EH, Kim YJ, Yamabe N, Park SH, Kim HK, Jang HJ, et al.
Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. J Ginseng Res 2014;38:22-7.
Kim SJ, Kim AK. Anti-breast cancer activity of fine black ginseng (Panax
ginseng Meyer) and ginsenoside Rg5. J Ginseng Res 2015;39:125-34.
Zhang Z, Du GJ, Wang CZ, Wen XD, Calway T, Li Z, et al.
Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions. Int J Mol Sci 2013;14:2980-95.
Wang W, Rayburn ER, Hao M, Zhao Y, Hill DL, Zhang R, et al.
Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate 2008;68:809-19.
Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM, Hsu SL, et al.
Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol 2005;55:531-40.
Kim JS, Joo EJ, Chun J, Ha YW, Lee JH, Han Y, et al.
Induction of apoptosis by ginsenoside rk1 in SK-MEL-2-human melanoma. Arch Pharm Res 2012;35:717-22.
Zuo G, Guan T, Chen D, Li C, Jiang R, Luo C, et al.
Total saponins of Panax
ginseng induces K562 cell differentiation by promoting internalization of the erythropoietin receptor. Am J Chin Med 2009;37:747-57.
Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Khatun S, Tamaya T, et al.
Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol 2001;22:339-41.
Li L, Wang Y, Qi B, Yuan D, Dong S, Guo D, et al.
Suppression of PMA-induced tumor cell invasion and migration by ginsenoside rg1 via the inhibition of NF-κB-dependent MMP-9 expression. Oncol Rep 2014;32:1779-86.
Lee SG, Kang YJ, Nam JO. Anti-metastasis effects of ginsenoside Rg3 in B16F10 cells. J Microbiol Biotechnol 2015;25:1997-2006.
Guo JQ, Zheng QH, Chen H, Chen L, Xu JB, Chen MY, et al.
Ginsenoside rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression. Int J Oncol 2014;45:1065-72.
Jung JS, Ahn JH, Le TK, Kim DH, Kim HS. Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro
invasion/migration of human astroglioma cells. Neurochem Int 2013;63:80-6.
Kim SY, Kim DH, Han SJ, Hyun JW, Kim HS. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem Pharmacol 2007;74:1642-51.
Yoon JH, Choi YJ, Cha SW, Lee SG. Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine 2012;19:284-92.
Kim H, Roh HS, Kim JE, Park SD, Park WH, Moon JY, et al.
Compound K attenuates stromal cell-derived growth factor 1 (SDF-1)-induced migration of C6 glioma cells. Nutr Res Pract 2016;10:259-64.
Huynh DL, Sharma N, Kumar Singh A, Singh Sodhi S, Zhang JJ, Mongre RK, et al.
Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis
, through regulating different signaling pathways. Chin J Nat Med 2017;15:15-40.
Chen YC, Shen SC, Lee WR, Lin HY, Ko CH, Shih CM, et al.
Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol 2002;76:351-9.
Wang J, Yu Y, Hashimoto F, Sakata Y, Fujii M, Hou DX, et al.
Baicalein induces apoptosis through ROS-mediated mitochondrial dysfunction pathway in HL-60 cells. Int J Mol Med 2004;14:627-32.
Chang WH, Chen CH, Lu FJ. Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines. Planta Med 2002;68:128-32.
Murashima T, Katayama H, Shojiro K, Nishizawa Y. Possible mechanism of growth inhibition by Scutellaria baicalensis
in an estrogen-responsive mouse tumor cell line. Oncol Rep 2011;25:1431-8.
Tkacz E, Kostka P, Komorowski D. Korean Scutellaria baicalensis
water extract inhibits cell cycle G1/S transition by suppressing cyclin D1 expression and matrix-metalloproteinase-2 activity in human lung cancer cells. J Ethnopharmacol 2011;133:634-41.
Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH, et al.
Wogonin, an active compound in Scutellaria baicalensis
, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine 2010;17:47-54.
Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, et al.
Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis
. Cancer Res 2003;63:4037-43.
Lu Z, Lu N, Li C, Li F, Zhao K, Lin B, et al.
Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. Toxicol Lett 2012;209:211-20.
Honda H, Nagai Y, Matsunaga T, Saitoh S, Akashi-Takamura S, Hayashi H, et al.
Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. J Leukoc Biol 2012;91:967-76.
Yu J, Lou Y. Influence of α-glycyrrhizic acid on metabolism of steroid hormone in kidney. Chin J Tradit Med Sci Technol 2006;13:246-7.
Nakamura S, Watanabe T, Tanigawa T, Shimada S, Nadatani Y, Miyazaki T, et al.
Isoliquiritigenin ameliorates indomethacin-induced small intestinal damage by inhibiting NOD-like receptor family, pyrin domain-containing 3 inflammasome activation. Pharmacology 2018;101:236-45.
Li H. Study of Liquiritin to Treat Depression on Pharmacodynamics and Its Possible Antidepressant Mechanisms. Beijing University of Chinese Medicine; 2008.
Qiao X, Ji S, Yu SW, Lin XH, Jin HW, Duan YK, et al.
Identification of key licorice constituents which interact with cytochrome P450: Evaluation by LC/MS/MS cocktail assay and metabolic profiling. AAPS J 2014;16:101-13.
He YX, Du M, Shi HL, Huang F, Liu HS, Wu H, et al.
Astragalosides from radix astragali benefits experimental autoimmune encephalomyelitis in C57BL/6 mice at multiple levels. BMC Complement Altern Med 2014;14:313.
Tang D, He B, Zheng ZG, Wang RS, Gu F, Duan TT, et al.
Inhibitory effects of two major isoflavonoids in radix astragali on high glucose-induced mesangial cells proliferation and AGEs-induced endothelial cells apoptosis. Planta Med 2011;77:729-32.
Xu A, Wang H, Hoo RL, Sweeney G, Vanhoutte PM, Wang Y, et al.
Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 2009;150:625-33.
Changchun Y, Jinkun W, Mei H. Effect of Astragalus
membranaceus and Angelica sinensis
on focal adhesion kinase expression and apoptosis of cultured vascular smooth muscle cells. Chin J Integr Tradit West Med 2003;23:201-3.
Fei ZW, Zhang XP, Zhang J, Huang XM, Wu DJ, Bi HH, et al.
Protective effects of radix astragali injection on multiple organs of rats with obstructive jaundice. Chin J Integr Med 2016;22:674-84.
Yeo CR, Yang C, Wong TY, Popovich DG. A quantified ginseng (Panax
ginseng C.A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules 2011;16:477-92.
Nakaya TA, Kita M, Kuriyama H, Iwakura Y, Imanishi J. Panax
ginseng induces production of proinflammatory cytokines via toll-like receptor. J Interferon Cytokine Res 2004;24:93-100.
Yoon SJ, Park JY, Choi S, Lee JB, Jung H, Kim TD, et al.
Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS. Biochem Biophys Res Commun 2015;463:1184-9.
Yanbin L, Yu L, Guangshu Y, Jiafeng Z, Yiqi H. Effect of Ginsenoside Rg1 on expression of integrin and regulation of signal transduction pathway in osteoblasts co-cultured with Ti particles. Chin J Tradit Med Traumatol Orthop 2017;5:5-8.
Lu ZF, Shen YX, Zhang P, Xu YJ, Fan ZH, Cheng MH, et al.
Ginsenoside Rg1 promotes proliferation and neurotrophin expression of olfactory ensheathing cells. J Asian Nat Prod Res 2010;12:265-72.
Wang Y, Cao HJ, Sun SJ, Dai JY, Fang JW, Li QH, et al.
Total flavonoid aglycones extract in radix scutellariae inhibits lung carcinoma and lung metastasis by affecting cell cycle and DNA synthesis. J Ethnopharmacol 2016;194:269-79.
Choi BB, Choi JH, Park SR, Kim JY, Hong JW, Kim GC, et al.
Scutellariae radix induces apoptosis in chemoresistant SCC-25 human tongue squamous carcinoma cells. Am J Chin Med 2015;43:167-81.
Cheng P, Wang T, Li W, Muhammad I, Wang H, Sun X, et al.
Baicalin alleviates lipopolysaccharide-induced liver inflammation in chicken by suppressing TLR4-mediated NF-κB pathway. Front Pharmacol 2017;8:547.
Liu X, Liu C. Baicalin ameliorates chronic unpredictable mild stress-induced depressive behavior: Involving the inhibition of NLRP3 inflammasome activation in rat prefrontal cortex. Int Immunopharmacol 2017;48:30-4.
Li-Ping Z, Jin G, Chang-Fa H, Wei-Zhen W. Inhibitory effect of 8 Chinese herbal decoctions on expression of C-erbB-1 in psorlatic keratinocytes. Chin J Integr Tradit West Med 2003;Suppl 1:195-7.
Zhang Q, Sun LJ, Yang ZG, Zhang GM, Huo RC. Influence of adipocytokines in periprostatic adipose tissue on prostate cancer aggressiveness. Cytokine 2016;85:148-56.
Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: The Liu-Wei-Di-Huang pill as a case study. Mol Biosyst 2014;10:1014-22.
Qi Q, Li R, Li HY, Cao YB, Bai M, Fan XJ, et al.
Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach. Acta Pharmacol Sin 2016;37:963-72.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9]
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking
| ||Jialin Li, Zhihong Huang, Shan Lu, Hua Luo, Yingying Tan, Peizhi Ye, Xinkui Liu, Zhishan Wu, Chao Wu, Antony Stalin, Haojia Wang, Yingying Liu, Liangliang Shen, Xiaotian Fan, Bei Zhang, Jianping Yi, Lu Yao, Yi Xu, Jiarui Wu, Xianchun Duan |
| ||Medicine. 2021; 100(51): e27112 |
|[Pubmed] | [DOI]|
||Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
| ||Jiahao Ye, Lin Li, Zhixi Hu, Baojun Xu |
| ||BioMed Research International. 2021; 2021: 1 |
|[Pubmed] | [DOI]|